Madrigal Statement on the Passing of Dr. Stephen Harrison
Madrigal Statement on the Passing of Dr. Stephen Harrison
CONSHOHOCKEN, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- The Madrigal team is shocked and saddened to learn of the passing of Dr. Stephen Harrison.
宾夕法尼亚州康舍霍肯，2024年4月24日（GLOBE NEWSWIRE）——得知斯蒂芬·哈里森博士去世，Madrigal团队感到震惊和悲伤。
We offer our deepest condolences to Stephen's family for their loss.
我们对斯蒂芬的家人损失表示最深切的慰问。
Stephen was a colleague and friend to so many of us at Madrigal. He worked tirelessly to improve the lives of people with nonalcoholic steatohepatitis (NASH), and his contributions to the field will touch countless families across the globe for decades to come. So many of the recent innovations and achievements we've seen in NASH research stemmed from his constant collaboration with partners in academia, industry, the regulatory sciences, and the patient community.
Stephen 是 Madrigal 许多人的同事和朋友。他孜孜不倦地努力改善非酒精性脂肪肝炎（NASH）患者的生活，他在该领域的贡献将在未来几十年内影响全球无数家庭。我们在NASH研究中看到的许多最新创新和成就都源于他与学术界、工业界、监管科学和患者社区合作伙伴的持续合作。
Stephen was much more than a brilliant investigator and physician; he was a true leader who inspired all of us with his commitment to patients. We'll remember his sense of humor, his courtesy, and his boundless energy and optimism.
斯蒂芬不仅是一位出色的调查员和医生；他是一位真正的领导者，他对患者的承诺激励了我们所有人。我们会记住他的幽默感、礼貌，以及他无限的活力和乐观情绪。
The field of hepatology has lost a true giant.
肝病学领域已经失去了一位真正的巨头。
Source: Madrigal Pharmaceuticals, Inc.
来源：Madrigal Pharmicals, Inc.